Wells Fargo’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$642K Sell
27,558
-42,680
-61% -$919K ﹤0.01% 4011
2025
Q4
$1.4M Buy
70,238
+29,268
+71% +$572K ﹤0.01% 3706
2025
Q3
$748K Buy
40,970
+6,376
+18% +$124K ﹤0.01% 4013
2025
Q2
$695K Sell
34,594
-330
-0.9% -$6.35K ﹤0.01% 3926
2025
Q1
$633K Sell
34,924
-2,098
-6% -$37.6K ﹤0.01% 3921
2024
Q4
$642K Buy
37,022
+10,637
+40% +$204K ﹤0.01% 4014
2024
Q3
$509K Buy
26,385
+1,483
+6% +$27.3K ﹤0.01% 3977
2024
Q2
$408K Buy
24,902
+3,378
+16% +$52.4K ﹤0.01% 4039
2024
Q1
$328K Buy
21,524
+1,699
+9% +$26.7K ﹤0.01% 4167
2023
Q4
$318K Buy
19,825
+3,765
+23% +$52.6K ﹤0.01% 4174
2023
Q3
$209K Sell
16,060
-12,511
-44% -$162K ﹤0.01% 4328
2023
Q2
$364K Buy
28,571
+11,339
+66% +$142K ﹤0.01% 4176
2023
Q1
$194K Sell
17,232
-18,506
-52% -$225K ﹤0.01% 4450
2022
Q4
$474K Sell
35,738
-1,511
-4% -$19.9K ﹤0.01% 3676
2022
Q3
$433K Buy
37,249
+30,793
+477% +$422K ﹤0.01% 3774
2022
Q2
$95K Sell
6,456
-123,939
-95% -$2.03M ﹤0.01% 4665
2022
Q1
$2.52M Sell
130,395
-2,846
-2% -$50.8K ﹤0.01% 3071
2021
Q4
$2.3M Sell
133,241
-148,062
-53% -$2.52M ﹤0.01% 3360
2021
Q3
$4.7M Sell
281,303
-70,143
-20% -$1.05M ﹤0.01% 2890
2021
Q2
$4.71M Buy
351,446
+70,880
+25% +$887K ﹤0.01% 2925
2021
Q1
$3.35M Buy
280,566
+34,173
+14% +$413K ﹤0.01% 3230
2020
Q4
$3.05M Buy
246,393
+981
+0.4% +$10.6K ﹤0.01% 3169
2020
Q3
$2.56M Buy
245,412
+60,751
+33% +$772K ﹤0.01% 3105
2020
Q2
$2.58M Buy
184,661
+23,107
+14% +$314K ﹤0.01% 3073
2020
Q1
$1.9M Sell
161,554
-138,613
-46% -$1.83M ﹤0.01% 3045
2019
Q4
$4.25M Sell
300,167
-59,332
-17% -$728K ﹤0.01% 2701
2019
Q3
$3.79M Sell
359,499
-1,539,734
-81% -$18.4M ﹤0.01% 2789
2019
Q2
$27.7M Buy
1,899,233
+141,043
+8% +$2M 0.01% 1260
2019
Q1
$24.7M Buy
1,758,190
+143,168
+9% +$2.32M 0.01% 1312
2018
Q4
$28.2M Buy
1,615,022
+218,641
+16% +$3.55M 0.01% 1165
2018
Q3
$21.3M Sell
1,396,381
-8,956
-0.6% -$129K 0.01% 1466
2018
Q2
$19.4M Sell
1,405,337
-30,305
-2% -$454K 0.01% 1521
2018
Q1
$23.9M Sell
1,435,642
-469,967
-25% -$7.25M 0.01% 1349
2017
Q4
$27M Sell
1,905,609
-57,643
-3% -$769K 0.01% 1268
2017
Q3
$27.7M Sell
1,963,252
-41,813
-2% -$553K 0.01% 1227
2017
Q2
$25.7M Sell
2,005,065
-121,529
-6% -$1.52M 0.01% 1228
2017
Q1
$29.4M Buy
2,126,594
+152,472
+8% +$1.79M 0.01% 1162
2016
Q4
$21.1M Buy
1,974,122
+503,394
+34% +$5.28M 0.01% 1317
2016
Q3
$16.2M Buy
1,470,728
+324,470
+28% +$3.79M 0.01% 1438
2016
Q2
$12.1M Buy
1,146,258
+56,403
+5% +$667K ﹤0.01% 1679
2016
Q1
$13.7M Sell
1,089,855
-65,423
-6% -$718K 0.01% 1539
2015
Q4
$12.2M Buy
1,155,278
+183,925
+19% +$1.69M ﹤0.01% 1661
2015
Q3
$6.97M Buy
971,353
+256,458
+36% +$3.49M ﹤0.01% 2070
2015
Q2
$12.9M Buy
714,895
+23,860
+3% +$410K 0.01% 1705
2015
Q1
$10.9M Buy
691,035
+344,901
+100% +$5.22M ﹤0.01% 1810
2014
Q4
$4.9M Buy
346,134
+261,913
+311% +$3.94M ﹤0.01% 2359
2014
Q3
$1.44M Buy
84,221
+9,733
+13% +$224K ﹤0.01% 3219
2014
Q2
$2.22M Sell
74,488
-89,969
-55% -$2.16M ﹤0.01% 2933
2014
Q1
$4.1M Buy
164,457
+30,897
+23% +$905K ﹤0.01% 2460
2013
Q4
$3.84M Sell
133,560
-1,033,210
-89% -$30.2M ﹤0.01% 2459
2013
Q3
$38.4M Buy
1,166,770
+412,055
+55% +$12.8M 0.02% 827
2013
Q2
$23.4M Buy
+754,715
New +$20.2M 0.01% 1041

Other funds holding INVA

Wells Fargo's INVA Position: Q1 2026 in Review

Wells Fargo reduced its Innoviva (INVA) stake by 61% in Q1 2026, selling an estimated $919K and leaving 27,558 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #4011.

Wells Fargo first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.4M in Q3 2013. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Wells Fargo held 27,558 shares of Innoviva worth $642K as of Q1 2026.
  • Wells Fargo sold 42,680 Innoviva shares in Q1 2026, an estimated $919K.
  • Innoviva made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4011 holding.
  • Wells Fargo first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Innoviva position peaked at $38.4M in Q3 2013.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.